Yi Dong

Dr. Yi Dong

Second Affiliated Hospital Zhejiang University School Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
WXWan-Qing Xu
Wan-Qing Xu
Rou-Min WangRou-Min Wang
Rou-Min Wang
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

1 May 2019 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
YCYu-Chao Chen
Yu-Chao Chen
HYHao Yu
Hao Yu
RWRou-Min Wang
Rou-Min Wang
JXJuan-Juan Xie
Juan-Juan Xie
WNWang Ni
Wang Ni
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

25 February 2021 in Genes
Verified
Journal Article
Open access
PDF file
Guo-Min YangGuo-Min Yang
Guo-Min Yang
Rou-Min WangRou-Min Wang
Rou-Min Wang
Nan XiaNan Xia
Nan Xia
ziwei zhengziwei zheng
ziwei zheng
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
Wilson’s disease (WD) is an autosomal recessive disorder caused by ATP7B pathogenic variants. This study aimed to show the geographical distribution and haplotype spectrum of three prevalent pathogenic variants (p.R778L, p.P992L, p.T935M) in mainland Chinese population and clarify whether the founder effect may account for their origins. We firstly summarized the frequency and geographical distribution of p.R778L, p.P992L and p.T935M in 715 WD patients. Then, to construct haplotypes associated with the three variants, Sanger sequencing and microsatellite typing at three dinucleotide-repeat markers (D13S314, D13S301, D13S316) flanking the ATP7B gene were performed in 102 WD families. An obvious regional-specific distribution feature was found in p.T935M. Linkage disequilibrium at the three markers was shown in all the three variants and we found the common haplotypes specific for p.R778L, p.P992L and p.T935M respectively, represented successively by 10-7-7, 10-9-5 and 12-4-8, which all exhibited great significance vs. the control chromosomes (p < 0.01). Meanwhile, haplotypes for the three variants differed from the studies in other regions to some extent. The common haplotypes we found indicate that three prevalent pathogenic variants emerge due to the founder effect. Furthermore, the study contributes to expand our knowledge of the genetic diversity of WD from a cross-regional perspective.

9 July 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
QLQuan-Fu Li
Quan-Fu Li
HCHao‐Ling Cheng
Hao‐Ling Cheng
LYLu Yang
Lu Yang
YMYin Ma
Yin Ma
JZJing‐Jing Zhao
Jing‐Jing Zhao
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
Background: Homozygous spinocerebellar ataxia type 3 (SCA3) patients, which have an expanded cytosine‐adenine‐guanine (CAG) repeat mutation in both alleles of ATXN3, are extremely rare. Clinical features and genetic characteristics of them were seldom studied.Methods: We analyzed seven newly homozygous SCA3 patients from five families and 14 homozygotes reported previously. An additional cohort of 30 heterozygous SCA3 patients were analyzed to compare age at onset (AAO).Results: Two out of seven SCA3 homozygotes had the minimum CAG repeats reported so far (55/56 and 56/58). Five patients appeared peripheral neuropathy and two had mild cognitive impairment. The AAO was significantly inversely correlated with both the large and small expanded CAG repeats (r = −.7682, p < .0001). The AAO was significantly earlier in homozygous SCA3 than heterozygous ones (32.81 ± 11.86 versus. 49.90 ± 9.73, p < .0001). In addition, the AAO of our seven homozygotes is elder compared to those reported previously (41.29 years vs. 28.57 years), which may be related to the fewer CAG repeats in our seven patients.Conclusion: Gene dosage effect may play an important role in the AAO and severity of disease, and homozygosity for ATXN3 enhances phenotypic severity. Our findings expand clinical features and genetic characteristics of homozygous SCA3 patients.

4 August 2021 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
WXWan-Qing Xu
Wan-Qing Xu
WNWang Ni
Wang Ni
Rou-Min WangRou-Min Wang
Rou-Min Wang
YDYi Dong
Yi Dong
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu

14 June 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
ZZZi-Wei Zheng
Zi-Wei Zheng
MXMeng-Hui Xu
Meng-Hui Xu
CSChuan-Bin Sun
Chuan-Bin Sun
Zhi-Ying WuZhi-Ying Wu
Zhi-Ying Wu
YDYi Dong
Yi Dong
Objective: We reported the case of a patient with Wilson's disease (WD) with acute-onset visual impairment and summarized previously reported cases to make physicians aware of the complicated clinical expressions of WD and improve diagnosis efficiency.Methods: The patient was recruited from the Second Affiliated Hospital of Zhejiang University School of Medicine. Clinical data, including cranial images, laboratory tests, and ophthalmic findings were obtained. The PubMed database was searched for published cases of WD with visual impairment.Results: We reported a 22-year-old male who presented with hand tremor, personality change, and acute-onset binocular vision blurring. WD was considered to be closely correlated with neuropsychiatric and ocular involvements. After low-copper diet and regular copper-chelation therapy, the related symptoms improved compared to before. Six WD cases of optic neuropathy have been reported, including ours. The patients usually had neurological and/or hepatic symptoms for a period without any treatment. All the reported cases manifested as acute episodes of visual changes, and the ocular manifestations improved after copper-chelation treatment.Conclusions: Excess copper accumulation may be a rare cause of visual impairment in patients with WD. While the etiology behind patients' acute-onset visual impairment remained uncertain, the possibility of WD should be considered through neuropsychiatric and hepatic symptoms, corneal K-F rings, decreased serum ceruloplasmin, and low likelihood or exclusion of other causes. Clinicians need to recognize this rare manifestation and give appropriate treatment to avoid misdiagnosis and unnecessary overtreatment.